33822768|t|Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration.
33822768|a|Age-related macular degeneration (AMD) damages the retinal pigment epithelium (RPE), the tissue that safeguards photoreceptor health, leading to irreversible vision loss. Polymorphisms in cholesterol and complement genes are implicated in AMD, yet mechanisms linking risk variants to RPE injury remain unclear. We sought to determine how allelic variants in the apolipoprotein E cholesterol transporter modulate RPE homeostasis and function. Using live-cell imaging, we show that inefficient cholesterol transport by the AMD risk-associated ApoE2 increases RPE ceramide, leading to autophagic defects and complement-mediated mitochondrial damage. Mitochondrial injury drives redox state-sensitive cysteine-mediated phase separation of ApoE2, forming biomolecular condensates that could nucleate drusen. The protective ApoE4 isoform lacks these cysteines and is resistant to phase separation and condensate formation. In Abca-/- Stargardt macular degeneration mice, mitochondrial dysfunction induces liquid-liquid phase separation of p62/SQSTM1, a multifunctional protein that regulates autophagy. Drugs that decrease RPE cholesterol or ceramide prevent mitochondrial injury and phase separation in vitro and in vivo. In AMD donor RPE, mitochondrial fragmentation correlates with ApoE and p62 condensates. Our studies demonstrate that major AMD genetic and biological risk pathways converge upon RPE mitochondria, and identify mitochondrial stress-mediated protein phase separation as an important pathogenic mechanism and promising therapeutic target in AMD.
33822768	101	133	age-related macular degeneration	Disease	MESH:D008268
33822768	135	167	Age-related macular degeneration	Disease	MESH:D008268
33822768	169	172	AMD	Disease	MESH:D008268
33822768	214	217	RPE	CellLine	CVCL:IQ82
33822768	293	304	vision loss	Disease	MESH:D014786
33822768	323	334	cholesterol	Chemical	MESH:D002784
33822768	374	377	AMD	Disease	MESH:D008268
33822768	419	422	RPE	CellLine	CVCL:IQ82
33822768	547	550	RPE	CellLine	CVCL:IQ82
33822768	627	638	cholesterol	Chemical	MESH:D002784
33822768	656	659	AMD	Disease	MESH:D008268
33822768	692	695	RPE	CellLine	CVCL:IQ82
33822768	696	704	ceramide	Chemical	MESH:D002518
33822768	760	780	mitochondrial damage	Disease	MESH:D028361
33822768	782	802	Mitochondrial injury	Disease	MESH:D028361
33822768	930	936	drusen	Disease	MESH:D015593
33822768	1063	1093	Stargardt macular degeneration	Disease	MESH:D000080362
33822768	1094	1098	mice	Species	10090
33822768	1100	1125	mitochondrial dysfunction	Disease	MESH:D028361
33822768	1168	1171	p62	Gene	18412
33822768	1172	1178	SQSTM1	Gene	18412
33822768	1252	1255	RPE	CellLine	CVCL:IQ82
33822768	1256	1267	cholesterol	Chemical	MESH:D002784
33822768	1271	1279	ceramide	Chemical	MESH:D002518
33822768	1288	1308	mitochondrial injury	Disease	MESH:D028361
33822768	1355	1358	AMD	Disease	MESH:D008268
33822768	1365	1368	RPE	CellLine	CVCL:IQ82
33822768	1370	1397	mitochondrial fragmentation	Disease	MESH:D012892
33822768	1423	1426	p62	Gene	18412
33822768	1475	1478	AMD	Disease	MESH:D008268
33822768	1530	1533	RPE	CellLine	CVCL:IQ82
33822768	1689	1692	AMD	Disease	MESH:D008268
33822768	Association	MESH:D028361	18412
33822768	Positive_Correlation	MESH:D002518	MESH:D002784
33822768	Association	MESH:D002784	MESH:D008268
33822768	Association	MESH:D012892	18412
33822768	Positive_Correlation	MESH:D002518	MESH:D028361
33822768	Positive_Correlation	MESH:D002784	MESH:D028361

